Deals & Transactions

Story

Topas Therapeutics extends Series B by EUR18m to EUR40m total

Topas Therapeutics extends Series B by EUR18m to EUR40m total

Topas Therapeutics GmbH (Topas), a private biotechnology company developing immune tolerance-inducing drugs to treat and potentially cure a variety of autoimmune diseases, today announced that the Company has successfully extended its Series B round with an additional EUR18 million (~USD22 million) raised, bringing the total for this financing to EUR40 million. All of Topas’ existing investors participated in the extension.

Story

LocalGlobe and MMC Ventures invest in Vira Health

LocalGlobe and MMC Ventures invest in Vira Health

Vira Health, a digital health company focused on improving long-term health for women, has raised GBP1.5 million in seed funding from LocalGlobe, MMC Ventures, and angel investors including Megumi Ikeda, Managing Director, Hearst Ventures, Andrea Zitna of Elvie, former Spotify executive Sofia Bendz, founder of GoCardless Matt Robinson, and Simon Lambert, former CTO, MOO.com, and Treatwell. 

Story

HMNC Brain Health raises EUR9m

HMNC Brain Health raises EUR9m

HMNC Brain Health (HMNC), a biotech company pioneering the development of personalised therapies in psychiatry powered by predictive companion diagnostics, has received an additional EUR9 million from its current investors.